Platinum Drug-Incorporating Polymeric Nanosystems for Precise Cancer Therapy

Small. 2023 May;19(21):e2208241. doi: 10.1002/smll.202208241. Epub 2023 Feb 26.

Abstract

Platinum (Pt) drugs are widely used in clinic for cancer therapy, but their therapeutic outcomes are significantly compromised by severe side effects and acquired drug resistance. With the emerging immunotherapy and imaging-guided cancer therapy, precise delivery and release of Pt drugs have drawn great attention these days. The targeting delivery of Pt drugs can greatly increase the accumulation at tumor sites, which ultimately enhances antitumor efficacy. Further, with the combination of Pt drugs and other theranostic agents into one nanosystem, it not only possesses excellent synergistic efficacy but also achieves real-time monitoring. In this review, after the introduction of Pt drugs and their characteristics, the recent progress of polymeric nanosystems for efficient delivery of Pt drugs is summarized with an emphasis on multi-modal synergistic therapy and imaging-guided Pt-based cancer treatment. In the end, the conclusions and future perspectives of Pt-encapsulated nanosystems are given.

Keywords: cancer theranostics; drug delivery; platinum drugs; polymeric nanosystems.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Drug Delivery Systems
  • Humans
  • Neoplasms* / drug therapy
  • Platinum
  • Polymers / therapeutic use
  • Prodrugs* / therapeutic use

Substances

  • Platinum
  • Prodrugs
  • Polymers
  • Antineoplastic Agents